
Only two weeks before, a federal jury found that Pfizer violated an antiracketeering law by promoting Neurontin for off-label uses, and awarded damages of $47 million, which is to be automatically tripled under the law. In 2004, Pfizer pleaded guilty to a criminal charge and agreed to pay $430 million to settle government investigations of its promotion of Neurontin. Pfizer has also said that it faces a number of lawsuits alleging use of Neurontin caused suicide, attempted suicide and other personal injuries. Neurontin was previously one of Pfizer's best-selling drugs, generating $2.7 billion in sales in 2003.
For more information visit on the suit: http://online.wsj.com/article/SB10001424052702304017404575165992338949212.html?mod=googlenews_wsj
For more information on this type of law suit:
www.injuryboard.com
www.shipmanlaw.com
0 comments:
Post a Comment